Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic's Q4 Revenues Drop 6 Percent; Swings to Loss

NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market on Wednesday that its fourth-quarter revenues declined 6 percent and it swung from a profit in the 2007 fourth quarter to a loss.

The Omaha, Neb.-based pharmacogenomics assay developer and lab services firm had revenues of $6.1 million for the three-month period ended December 31, compared to revenues of $6.5 million for the fourth quarter of 2007.

It swung to a net loss of $219,000, or $.00, per share, from a profit of $212,000, or $.00 per share, in the fourth quarter of 2007.

Transgenomic's R&D spending dropped to $649,000 from $763,000, and its SG&A spending fell to $2 million from $2.7 million year over year.

For full-year 2008, Transgenomic's revenues increased slightly to $24 million from $23.2 million. Its net loss declined to $495,000, or $.01 per share, from $2.1 million, or $.04 per share, for 2007. Its R&D spending decreased to $2.5 million from $3 million, while its SG&A spending fell to $10.8 million from $11.5 million.

Transgenomic President and CEO Craig Tuttle noted in a statement that revenue from the firm's molecular reference lab grew 70 percent in 2008.

"With this growth in our services business, our previous significant effort in cost reduction and investment in our sales organization, we have achieved close to breakeven performance for the year," said Tuttle.

The firm finished 2008 with $4.8 million in cash and cash equivalents.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.